Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03464409 · ClinicalTrials.gov registry record · NA

Supporting Patient Decisions About UE Surgery in Cervical SCI

A NA study of Cervical Spinal Cord Injury, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
46
Enrollment target
4
Study locations

NCT03464409: Completed NA study of Cervical Spinal Cord Injury, sponsored by Washington University School of Medicine.

NCT03464409 is a NA study of Cervical Spinal Cord Injury that has completed, run by Washington University School of Medicine. The registered enrollment target is 46 participants, above the 20-participant average among 18 other Cervical Spinal Cord Injury trials with a reported enrollment target (130% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03464409, a NA study of Cervical Spinal Cord Injury, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
4
Study locations

Study Summary

The goal of this study is to collect and describe patient and caregiver reported outcomes regarding surgical and non-surgical treatment for improving hand and arm function in the setting of cervical spinal cord injury. Eligible study participants will be recruited across the 4 sites and the investigators plan to recruit the following groups and numbers of participants: 1. Nerve or tendon transfer recipients: people who have elected to undergo nerve (N=10) or tendon (N=10) transfer surgery to restore some hand and arm function as part of their standard clinical care and their caregiver (N=20) 2. Non-surgical control group: people with cervical SCI (N=20) and their caregiver (N=20)

Primary Outcome

All interviews will be transcribed verbatim and analyzed using standard qualitative text analysis. Members of the research team will read the transcripts for accuracy and to determine potential topics for coding. The investigators will develop a codebook using inductive and deductive codes. Deductive codes will be directly linked to our research questions. Adding inductive codes, where topics and codes are not pre-determined but are derived directly from the data, will allow the research team to

Interventions

  • OTHER Semi-structured interview
  • OTHER Spinal Cord Independence Measure (SCIM-SR)
  • OTHER SF-36

Study Locations (4)

California

  • Veterans Affairs Palo Alto Health Care System - Palo Alto
  • Stanford University - Stanford

Missouri

  • Veterans Affairs St. Louis Health Care System - St Louis
  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2018-03-13
Est. Completion 2021-08-30
Phase NA

What the finished NCT03464409 record still lists

NCT03464409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, above the 20-participant average among 18 other Cervical Spinal Cord Injury trials with a reported enrollment target (130% higher).

The record links to 1 condition, with Cervical Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which Semi-structured interview is the first listed.

NCT03464409 reports a single indexed study location in California, Missouri.

Frequently Asked Questions

What is clinical trial NCT03464409 about?

NCT03464409 is a clinical study titled "Supporting Patient Decisions About UE Surgery in Cervical SCI". The goal of this study is to collect and describe patient and caregiver reported outcomes regarding surgical and non-surgical treatment for improving hand and arm function in the setting of cervical spinal cord injury. Eligible study participants will be recruited across the 4 sites and the investig...

What is the current status of trial NCT03464409?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-03-13. Estimated completion is 2021-08-30.

What conditions does trial NCT03464409 study?

This clinical trial studies the following conditions: Cervical Spinal Cord Injury.

What interventions are being tested in trial NCT03464409?

The interventions under investigation include: Semi-structured interview (OTHER), Spinal Cord Independence Measure (SCIM-SR) (OTHER), SF-36 (OTHER).

Who is sponsoring clinical trial NCT03464409?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03464409 being conducted?

This trial has 4 study locations across California, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03464409's enrollment target sits among peer trials

46 3rd of 18 higher than 16 of 18 other Cervical Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cervical Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03464409, the US trial registry maintained by the National Library of Medicine. NCT03464409 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.